Stocktoria
QHSLab, Inc. USAQ
OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2002-01-09
QHSLab, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7M | $2.1M | $1.4M | $1.2M | $1.4M | $124,532 | — | — | — | — |
| Gross profit | $1.8M | $1.4M | $793,607 | $619,519 | $670,748 | $50,093 | — | — | — | — |
| R&D expense | $484,873 | $294,479 | $214,008 | $190,117 | $90,874 | $98,290 | $100,230 | — | — | — |
| Operating income | $131,244 | $205,738 | -$240,158 | -$560,539 | -$502,258 | -$275,105 | -$154,100 | -$27,379 | -$105 | -$23,248 |
| Interest expense | $237,413 | $465,055 | $230,494 | $433,442 | $246,490 | $30,984 | $12,416 | $11,252 | $11,251 | $11,282 |
| Income tax | — | — | — | $0 | — | — | — | — | — | — |
| Net income | -$457,417 | -$259,239 | -$468,362 | -$996,001 | -$770,176 | -$327,388 | -$166,516 | -$38,631 | -$11,356 | -$23,248 |
| EPS (diluted) | $0.02 | $-0.03 | $-0.05 | $-0.11 | — | — | — | — | — | — |
| Operating cash flow | -$178,118 | $142,437 | -$159,627 | -$350,994 | -$354,738 | -$165,564 | -$134,838 | -$39,533 | -$105 | -$13,929 |
| Cash & equivalents | $636,157 | $157,168 | $51,582 | $178,694 | $286,855 | $94,342 | $23,590 | $0 | — | — |
| Inventory | $35,790 | $41,779 | $25,181 | $51,840 | $65,740 | $99,701 | — | — | — | — |
| Total assets | $2.2M | $1.8M | $1.7M | $2.0M | $2.2M | $297,863 | $26,340 | $1,750 | $0 | $0 |
| Total liabilities | $546,078 | $2.4M | $2.1M | $1.9M | $1.4M | $906,189 | $456,131 | $535,265 | $494,884 | $483,528 |
| Shareholders' equity | $1.6M | -$607,756 | -$375,617 | $76,245 | $824,066 | -$608,326 | -$429,791 | -$533,515 | -$494,884 | -$483,528 |
Growth · year-over-year · Revenue CAGR 84.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +26.3% | +51.3% | +13.3% | -12.1% | +1035.8% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.